Exact Mass: 360.2152016

Exact Mass Matches: 360.2152016

Found 46 metabolites which its exact mass value is equals to given mass value 360.2152016, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

9-Fluoro-16alpha-methylpregn-4-ene-3,11,20-trione

9-Fluoro-16-methylpregn-4-ene-3,11,20-trione, (16alpha)-

C22H29FO3 (360.2100616)


   

9-Fluoro-2alpha-methyl-11-oxoprogesterone

9-Fluoro-2alpha-methylpregn-4-ene-3,11,20-trione; 9-Fluoro-2alpha-methyl-11-oxoprogesterone

C22H29FO3 (360.2100616)


   

5,7,3',4'-Tetrahydroxyflavanone 7-alpha-L-arabinofuranosyl-(1->6)-glucoside

1,3,3,4,9,9-hexamethyl-1,3,9,9a-tetrahydro-4H-spiro[furo[3,2-b]quinoline-2,2-indole]

C24H28N2O (360.2201518)


5,7,3,4-tetrahydroxyflavanone 7-alpha-l-arabinofuranosyl-(1->6)-glucoside is a member of the class of compounds known as hydroquinolines. Hydroquinolines are derivatives of quinoline in which in which at least one double bond in the quinoline moiety are reduced by adding two hydrogen atoms. 5,7,3,4-tetrahydroxyflavanone 7-alpha-l-arabinofuranosyl-(1->6)-glucoside is practically insoluble (in water) and an extremely weak basic (essentially neutral) compound (based on its pKa). 5,7,3,4-tetrahydroxyflavanone 7-alpha-l-arabinofuranosyl-(1->6)-glucoside can be found in pomegranate, which makes 5,7,3,4-tetrahydroxyflavanone 7-alpha-l-arabinofuranosyl-(1->6)-glucoside a potential biomarker for the consumption of this food product.

   
   
   
   
   
   
   
   

(2S,3S)-3-decyl-2-hydroxy-2-(3-methoxy-3-oxopropyl)butanedioic acid

NCGC00381440-01!(2S,3S)-3-decyl-2-hydroxy-2-(3-methoxy-3-oxopropyl)butanedioic acid

C18H32O7 (360.21479220000003)


   
   

Scopolamine-N-butyl

Scopolamine-N-butyl

[C21H30NO4]+ (360.21747200000004)


CONFIDENCE standard compound; INTERNAL_ID 2515

   
   
   
   

LY255283

1-[5-ethyl-2-hydroxy-4-[[6-methyl-6-(1H-tetrazol-5-yl)heptyl]oxy]phenyl]-ethanone

C19H28N4O3 (360.2161298)


D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D020024 - Leukotriene Antagonists D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists

   

3,4,5-TRIFLUORO-4-(TRANS-4-PENTYLCYCLOHEXYL)-1,1-BIPHENYL

3,4,5-TRIFLUORO-4-(TRANS-4-PENTYLCYCLOHEXYL)-1,1-BIPHENYL

C23H27F3 (360.2064738)


   

2-(dicyclohexylphosphino)acetophenone &

2-(dicyclohexylphosphino)acetophenone &

C22H33O2P (360.22180480000003)


   

3,5-Di-O-(tert-butyldimethylsilyl)-2-deoxy-D-ribonolactone

3,5-Di-O-(tert-butyldimethylsilyl)-2-deoxy-D-ribonolactone

C17H36O4Si2 (360.2152016)


   

tris(2-methylpropyl) 2-hydroxypropane-1,2,3-tricarboxylate

tris(2-methylpropyl) 2-hydroxypropane-1,2,3-tricarboxylate

C18H32O7 (360.21479220000003)


   

1-Tetradecyl-3-Methylimidazolium Bromide

1-Tetradecyl-3-Methylimidazolium Bromide

C18H37BrN2 (360.2139942)


   

9-Fluoro-16-methylpregn-4-ene-3,11,20-trione, (16alpha)-

9-Fluoro-16-methylpregn-4-ene-3,11,20-trione, (16alpha)-

C22H29FO3 (360.2100616)


   

9-Fluoro-2-methylpregn-4-ene-3,11,20-trione, (2alpha)-

9-Fluoro-2-methylpregn-4-ene-3,11,20-trione, (2alpha)-

C22H29FO3 (360.2100616)


   

Bis(trimethylsilyl) undecanedioate

Bis(trimethylsilyl) undecanedioate

C17H36O4Si2 (360.2152016)


   

Butylscopolamine

Butylscopolamine

C21H30NO4+ (360.21747200000004)


A carboxylic ester resulting from the formal condensation of the carboxy group of (2S)-3-hydroxy-2-phenylpropanoic acid with the hydroxy group of (2R,4S,5S,7s)-9-butyl-7-hydroxy-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.0(2,4)]nonane. A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03B - Belladonna and derivatives, plain > A03BB - Belladonna alkaloids, semisynthetic, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists

   

amino{[4-({N-[(2S)-3-carboxy-2-hydroxypropanoyl]-L-leucyl}amino)butyl]amino}methaniminium

amino{[4-({N-[(2S)-3-carboxy-2-hydroxypropanoyl]-L-leucyl}amino)butyl]amino}methaniminium

C15H30N5O5+ (360.224683)


   
   
   
   
   

12-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxododecanoic acid

12-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxododecanoic acid

C18H32O7 (360.21479220000003)


   

(11R)-11-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxododecanoic acid

(11R)-11-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxododecanoic acid

C18H32O7 (360.21479220000003)


   

(2S,3S)-3-decyl-2-hydroxy-2-(3-methoxy-3-oxopropyl)butanedioic acid

(2S,3S)-3-decyl-2-hydroxy-2-(3-methoxy-3-oxopropyl)butanedioic acid

C18H32O7 (360.21479220000003)


   
   
   
   

[(1S,2S,4S,5R)-9-butyl-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate

[(1S,2S,4S,5R)-9-butyl-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate

C21H30NO4+ (360.21747200000004)


   

10-Isopropyl-3,3-dimethyl-11-phenyl-2,3,4,5,10,11-hexahydro-1H-dibenzo(B,E)(1,4)-diazepin-1-one

10-Isopropyl-3,3-dimethyl-11-phenyl-2,3,4,5,10,11-hexahydro-1H-dibenzo(B,E)(1,4)-diazepin-1-one

C24H28N2O (360.2201518)


   
   

3,4,10,16-tetrahydroxy-5,7-dimethyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-7-ium

3,4,10,16-tetrahydroxy-5,7-dimethyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-7-ium

[C21H30NO4]+ (360.21747200000004)


   

(1r,3r,4s,5r,7s,8r,9s,10s,11s,14r,16r,17s,18r)-3,4,10,16-tetrahydroxy-5,7-dimethyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-7-ium

(1r,3r,4s,5r,7s,8r,9s,10s,11s,14r,16r,17s,18r)-3,4,10,16-tetrahydroxy-5,7-dimethyl-12-methylidene-7-azaheptacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁷,¹⁶.0⁹,¹⁴.0¹⁴,¹⁸]nonadecan-7-ium

[C21H30NO4]+ (360.21747200000004)